Funder
Consejo Nacional de Ciencia y Tecnología
Instituto Mexicano del Seguro Social
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. World Health Organization (2014) Ageing and life-course. Facts about ageing.
http://www.who.int/ageing/about/facts/es/
. Accessed 13 Nov 2018
2. International Conference on Harmonisation ICH Harmonised tripartite guideline studies in support of special populations: Geriatrics E7 (1993).
http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E7/Step4/E7_Guideline.pdf
. Accessed 13 Nov 2018
3. Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Bates DW (2001) Risk factors for adverse drug events among nursing home residents. Arch Intern Med 161:1629–1634
4. Herr M, Robine JM, Pinot J, Arvieu JJ, Ankri J (2015) Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf 24:637–646
5. Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S (2009) Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 26:1039–1048
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献